HomeONCT • NASDAQ
add
Oncternal Therapeutics Inc
Previous close
$8.96
Year range
$5.57 - $13.14
Market cap
25.88M USD
Avg Volume
6.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 297.00K | 73.68% |
Operating expense | 3.26M | -0.76% |
Net income | -9.16M | 19.61% |
Net profit margin | -3.09K | 53.72% |
Earnings per share | -3.11 | 22.25% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 34.26M | -46.24% |
Total assets | 36.73M | -46.50% |
Total liabilities | 6.68M | -13.08% |
Total equity | 30.05M | — |
Shares outstanding | 2.96M | — |
Price to book | 0.88 | — |
Return on assets | -60.28% | — |
Return on capital | -71.16% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.16M | 19.61% |
Cash from operations | -6.42M | 28.69% |
Cash from investing | -1.81M | 93.18% |
Cash from financing | -1.00K | -100.05% |
Net change in cash | -8.23M | 75.43% |
Free cash flow | -3.40M | 31.47% |
About
Founded
1997
Website
Employees
27